Use of real-world data (RWD) has been gaining attention across the regulatory industry. While the current application of RWD has been limited to specific cases, there is a potential to further explore and develop its application.
In this article published on Clinical Therapeutics we analyze data from 27 cases in which RWD were applied in regulatory approval to: